By submitting this form, you are agreeing to the Terms of Use and Privacy Policy.
Syringe labels are essential for hospitals and pharmacies because they reduce the possibility of giving patients the incorrect drugs or prescriptions. To expeditiously administer a drug to a patient and guarantee proper dosage, medications are frequently pre-loaded into syringes.
The availability of injectable medications, however, also raises the danger of improper administration. Even though health professionals are trained to handle these things properly, a few situations have happened as a result of incorrect labelling or a lack of identification.
The improper medication or dose can easily be administered using an unlabeled syringe. Furthermore, any unmarked item containing a medication or anaesthesia will frequently pass through multiple hands.
The writing on the identification could smear or deteriorate throughout this transit. Other times, it might not be labelled, making it challenging to locate the medication once it gets there.
Another illustration would be filling a syringe with medication and leaving it in a location where saline flushes are kept. This could lead to the IV unintentionally being flushed with a medication instead of saline.
The Global Syringe Labels market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
For its syringe product line of compounded sterile products (CSPs), QuVa Pharma, Inc. stated that it has introduced a new flag label design for which it has applied for a design patent.
These updated labels were created by QuVa Pharma in collaboration with its clients, and the company has started to change the labels on all of its needles.
A quality improvement targeted at lowering medication and dosing errors is the delivery of an improved syringe label with complete drug and dosing visibility, regardless of syringe orientation.
